Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer
Research output: Contribution to journal › Journal article › Research › peer-review
This study describes the radiosynthesis, in vitro and in vivo evaluation of the novel small peptide radioligand, 4-[(18)F]fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH(2,) ([(18)F]FBA-FALGEA-NH(2)) as a positron emission tomography (PET) tracer for imaging of the cancer specific epidermal growth factor receptor (EGFR) variant III mutation, EGFRvIII.
| Original language | English |
|---|---|
| Journal | Nuclear Medicine and Biology |
| Volume | 38 |
| Issue number | 4 |
| Pages (from-to) | 509-515 |
| Number of pages | 7 |
| ISSN | 0969-8051 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 33790946